Share:
Peer-Reviewed Publication
Dermatology2023;239(2):283-286.January 1, 2023Journal Article

Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.

Jazzmin C Williams1, Raed Alhusayen2, Sandra Guilbault3, Nancy K Hills4, John R Ingram5, Margaret V Kudlinski6, Michelle A Lowes7, Angelo V Marzano8,9, Maia Paul10, Bente Villumsen11, Christine A Yannuzzi12, Haley B Naik6
1Department of Dermatology, University of California San Francisco, San Francisco, California, USA, jazzmin.williams@ucsf.edu.
2Dermatology Division, Department of Medicine, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
3Hope for HS, Troy, Michigan, USA.
4Department of Neurology, Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
5Division of Infection and Immunity, Department of Dermatology and Academic Wound Healing, Cardiff University, Cardiff, UK.
6Department of Dermatology, University of California San Francisco, San Francisco, California, USA.
7The Rockefeller University, New York, New York, USA.
8Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
9Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
10Reify Health, Boston, Massachusetts, USA.
11Patientforeningen HS Danmark, Copenhagen, Denmark.
12HS Warriors, Port Richey, Florida, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.